2019 APSC共识建议:急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估

2019-12-18 国外心血管相关专家小组(统称) Circ J. 2019 Dec 18.

2019年12月,亚太心脏病学会(APSC)发布了急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估共识建议,文章主要针对急诊疑似急性冠脉综合征患者应用高敏肌钙蛋白T(hs-TnT )评估提供指导建。

中文标题:

2019 APSC共识建议:急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估

英文标题:

The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department.

发布日期:

2019-12-18

简要介绍:

2019年12月,亚太心脏病学会(APSC)发布了急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估共识建议,文章主要针对急诊疑似急性冠脉综合征患者应用高敏肌钙蛋白T(hs-TnT )评估提供指导建。

 

拓展指南:急性冠脉综合征相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 APSC共识建议:急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估)] GetToolGuiderByIdResponse(projectId=1, id=717d61c0018a4036, title=2019 APSC共识建议:急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估, enTitle=The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department., guiderFrom=Circ J. 2019 Dec 18., authorId=null, author=, summary=2019年12月,亚太心脏病学会(APSC)发布了急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估共识建议,文章主要针对急诊疑似急性冠脉综合征患者应用高敏肌钙蛋白T(hs-TnT )评估提供指导建。 , cover=, journalId=null, articlesId=null, associationId=738, associationName=国外心血管相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Dec 18 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年12月,亚太心脏病学会(APSC)发布了急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估共识建议,文章主要针对急诊疑似急性冠脉综合征患者应用高敏肌钙蛋白T(hs-TnT )评估提供指导建。 </P> <P> </P>拓展指南:<strong>与<font color=red>急性冠脉综合征</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=a1e7c1c001811ae5" title="2019 KSC心脏康复指南:急性冠脉综合征后心脏康复和二级预防建议" target=_blank>2019 KSC心脏康复指南:急性冠脉综合征后心脏康复和二级预防建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=31a891c001e7562d" title="2019 EHRA共识:急性冠脉综合征和血运重建紧急情况下的心律失常" target=_blank>2019 EHRA共识:急性冠脉综合征和血运重建紧急情况下的心律失常</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=fff041c001ea264b" title="2019 EAPCI专家共识:冠脉腔内影像学检查的临床应用-第2部分:急性冠脉综合征冠脉造影结果模糊患者介入治疗决策指导" target=_blank>2019 EAPCI专家共识:冠脉腔内影像学检查的临床应用-第2部分:急性冠脉综合征冠脉造影结果模糊患者介入治疗决策指导</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=40ed41c001e35370" title="急性冠脉综合征急诊快速诊治指南(2019)" target=_blank>急性冠脉综合征急诊快速诊治指南(2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f01cc1c001e290f8" title="2018 JCS指南:急性冠脉综合征的诊断和治疗" target=_blank>2018 JCS指南:急性冠脉综合征的诊断和治疗</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%80%A5%E6%80%A7%E5%86%A0%E8%84%89%E7%BB%BC%E5%90%88%E5%BE%81" target=_blank>有关急性冠脉综合征更多指南</a></ul>, tagList=[TagDto(tagId=360, tagName=急性冠脉综合征), TagDto(tagId=98194, tagName=高敏肌钙蛋白T评估)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4833, appHits=315, showAppHits=20, pcHits=2482, showPcHits=2795, likes=69, shares=9, comments=4, approvalStatus=1, publishedTime=Thu Dec 26 23:44:07 CST 2019, publishedTimeString=2019-12-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Dec 26 23:44:07 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 04:53:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 APSC共识建议:急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估)])
2019 APSC共识建议:急诊疑似急性冠脉综合征患者高敏肌钙蛋白T评估
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070523, encodeId=5e8b10e0523ce, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc8c5692922, createdName=荔枝zje, createdTime=Mon Nov 15 20:38:02 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922238, encodeId=474b92223884, content=好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82835425273, createdName=ms1000002114140855, createdTime=Tue Feb 02 16:34:36 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904977, encodeId=3c379049e711, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02a5441513, createdName=ms4000001006871718, createdTime=Fri Dec 04 21:26:31 CST 2020, time=2020-12-04, status=1, ipAttribution=)]
    2021-11-15 荔枝zje

    好好好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070523, encodeId=5e8b10e0523ce, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc8c5692922, createdName=荔枝zje, createdTime=Mon Nov 15 20:38:02 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922238, encodeId=474b92223884, content=好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82835425273, createdName=ms1000002114140855, createdTime=Tue Feb 02 16:34:36 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904977, encodeId=3c379049e711, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02a5441513, createdName=ms4000001006871718, createdTime=Fri Dec 04 21:26:31 CST 2020, time=2020-12-04, status=1, ipAttribution=)]
    2021-02-02 ms1000002114140855

    好好好好好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070523, encodeId=5e8b10e0523ce, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc8c5692922, createdName=荔枝zje, createdTime=Mon Nov 15 20:38:02 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922238, encodeId=474b92223884, content=好好好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82835425273, createdName=ms1000002114140855, createdTime=Tue Feb 02 16:34:36 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904977, encodeId=3c379049e711, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02a5441513, createdName=ms4000001006871718, createdTime=Fri Dec 04 21:26:31 CST 2020, time=2020-12-04, status=1, ipAttribution=)]
    2020-12-04 ms4000001006871718

    很好

    0